Progesterone Signaling in Intestinal Tumorigenesis
Author Information
Author(s): Heijmans Jarom, Muncan Vanesa, Jacobs Rutger J., de Jonge-Muller Eveline S. M., Graven Laura, Biemond Izak, Ederveen Antwan G., Groothuis Patrick G., Mosselman Sietse, Hardwick James C., Hommes Daniel W., van den Brink Gijs R.
Primary Institution: Leiden University Medical Center
Hypothesis
Does progesterone signaling have a protective effect on colon cancer development?
Conclusion
The study found no evidence that progesterone signaling or progestin treatment affects intestinal tumorigenesis in rodent models.
Supporting Evidence
- The progesterone receptor was not expressed in the intestinal epithelium of mice or humans.
- No changes in polyp number, size, or localization were observed in PRKO-ApcMin/+ mice compared to ApcMin/+ mice.
- Treatment with progestins did not affect intestinal morphology or epithelial proliferation.
Takeaway
The researchers wanted to see if a hormone called progesterone helps prevent colon cancer, but they found out it doesn't work that way in mice.
Methodology
The study involved crossing mice lacking the progesterone receptor with a mouse model for intestinal polyposis and treating them with progestins to observe effects on tumor development.
Potential Biases
Potential bias due to funding from a pharmaceutical company that produces hormonal treatments.
Limitations
The study primarily focused on rodent models, which may not fully represent human biology.
Participant Demographics
Mice and rats were used in the experiments, with specific strains mentioned.
Statistical Information
P-Value
p=0.003 for risk reduction in the WHI study, but not applicable to this study's findings.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website